Prelude Therapeutics, Inc. (PRLD)
1.65
-0.05
(-2.94%)
USD |
NASDAQ |
Dec 10, 16:00
1.65
0.00 (0.00%)
After-Hours: 20:00
Prelude Therapeutics Price: 1.65 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 95.17 |
| Nautilus Biotechnology, Inc. | 2.04 |
| Protalix Biotherapeutics, Inc. | 1.80 |
| ALX Oncology Holdings, Inc. | 1.54 |
| Erasca, Inc. | 3.26 |
Price Related Metrics
| PS Ratio | 11.13 |
| Price to Book Value | 1.772 |
| Earnings Yield | -97.78% |
| Market Cap | 103.73M |